Sep. 13, 2024 — Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and ... New Alzheimer's Studies ...

The research paper, “APOLLOE4 Phase 3 Study of Oral ALZ-801/Valiltramiprosate in APOE ε4/ε4 Homozygotes with Early Alzheimer’s Disease: Trial Design & Baseline Characteristics,” was ...

Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...

Clinical trials need to evolve screening criteria to include diverse patient groups as more Alzheimer's disease drugs become ...

The following is a summary of “Association of vascular risk factors and cerebrovascular pathology with Alzheimer disease ...

September is World Alzheimer's Month and this year’s theme is “Time to act on dementia, time to act on Alzheimer’s." ...

FourNet & Alzheimer’s Society in the finals at European Contact Centre and Customer Service Awards 2024 to be held November ...

Analyst Andrew Fein from H.C. Wainwright reiterated a Buy rating on AC Immune SA (ACIU – Research Report) and keeping the price target at ...

Researchers also noticed that the mice used as models for Alzheimer’s disease who were given stool transplants from healthy ...

The GE HealthCare imaging tool is coming out as pharma companies release new therapies onto the market to help treat the ...

Researchers demonstrated that several findings in Alzheimer's disease are observed across disorders, identifying potential ...